We are live on
!
Find out more
Natixis Advisors Portfolio holdings
AUM
$71.9B
1-Year Est. Return
28.03%
This Fund
S&P 500
This Quarter
Est. Return
-3.85%
1 Year Est. Return
+28.03%
3 Year Est. Return
+95.12%
5 Year Est. Return
+131.42%
10 Year Est. Return
+475.22%
AUM
$23.6B
AUM Growth
+$900M
(+4%)
Cap. Flow
+$1.81B
Cap. Flow
% of AUM
7.66%
Top 10 Holdings %
Top 10 Hldgs %
15.31%
Holding
1,542
New
90
Increased
818
Reduced
532
Closed
102
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$149M |
| 2 |
Apple
AAPL
|
+$102M |
| 3 |
Amazon
AMZN
|
+$85.4M |
| 4 |
Vanguard Morningstar Value ETF
VTV
|
+$67.1M |
| 5 |
Microsoft
MSFT
|
+$51M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$31.5M |
| 2 |
Nutrien
NTR
|
+$29.5M |
| 3 |
AT&T
T
|
+$28.9M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$27.6M |
| 5 |
Sanofi
SNY
|
+$27.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.61% |
| 2 | Healthcare | 14.15% |
| 3 | Financials | 13.71% |
| 4 | Consumer Discretionary | 9.67% |
| 5 | Industrials | 9.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
State Street Energy Select Sector SPDR ETF
XLE
$39B
| $1.02M | ﹤0.01% |
28,458
-450
| -2% | -$17K |
|
1102
ArcBest
ARCB
$3.16B
| $1.01M | ﹤0.01% |
13,958
+2,663
| +24% | +$214K |
|
1103
Sun Life Financial
SLF
$45.6B
| $1.01M | ﹤0.01% |
25,469
+12,956
| +104% | +$581K |
|
1104
Teradyne
TER
$50B
| $1.01M | ﹤0.01% |
13,464
-23,610
| -64% | -$2.15M |
|
1105
Glaukos
GKOS
$9.49B
| $1.01M | ﹤0.01% |
18,990
+8,038
| +73% | +$415K |
|
1106
CRISPR Therapeutics
CRSP
$4.69B
| $1.01M | ﹤0.01% |
15,457
-1,676
| -10% | -$121K |
|
|
PRFT
1107
DELISTED
Perficient Inc
PRFT
| $1.01M | ﹤0.01% |
15,536
-3,847
| -20% | -$321K |
|
1108
Essential Utilities
WTRG
$11.5B
| $1.01M | ﹤0.01% |
24,378
+4,709
| +24% | +$228K |
|
1109
Myriad Genetics
MYGN
$476M
| $1M | ﹤0.01% |
52,568
+34,873
| +197% | +$800K |
|
1110
ArcelorMittal
MT
$49.5B
| $1M | ﹤0.01% |
50,311
+4,528
| +10% | +$104K |
|
1111
Olin
OLN
$2.53B
| $995K | ﹤0.01% |
23,211
+2,785
| +14% | +$141K |
|
1112
iShares S&P Mid-Cap 400 Growth ETF
IJK
$10.6B
| $994K | ﹤0.01% |
15,779
-3,171
| -17% | -$219K |
|
1113
Brink's
BCO
$5.01B
| $986K | ﹤0.01% |
20,359
-4,903
| -19% | -$273K |
|
1114
Nu Holdings
NU
$67.8B
| $979K | ﹤0.01% |
222,589
+151,380
| +213% | +$695K |
|
1115
Pearson
PSO
$10.6B
| $979K | ﹤0.01% |
102,481
+49,589
| +94% | +$494K |
|
1116
Cracker Barrel
CBRL
$1.26B
| $977K | ﹤0.01% |
+10,552
| New | +$1.06M |
|
|
ITCI
1117
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $977K | ﹤0.01% |
21,006
+2,099
| +11% | +$110K |
|
1118
VF Corp
VFC
$5.92B
| $968K | ﹤0.01% |
32,372
-61,255
| -65% | -$2.64M |
|
1119
Cemex
CX
$16.9B
| $960K | ﹤0.01% |
279,900
+14,164
| +5% | +$56K |
|
1120
NNN REIT
NNN
$9.29B
| $947K | ﹤0.01% |
23,770
+7,698
| +48% | +$347K |
|
1121
Aegon
AEG
$13.3B
| $945K | ﹤0.01% |
238,598
+3,890
| +2% | +$16.9K |
|
1122
Vanguard Tax-Exempt Bond Index Fund
VTEB
$45.2B
| $945K | ﹤0.01% |
+19,627
| New | +$981K |
|
1123
Enpro
NPO
$6.26B
| $939K | ﹤0.01% |
+11,052
| New | +$1.01M |
|
1124
Oshkosh
OSK
$8.82B
| $938K | ﹤0.01% |
13,344
+470
| +4% | +$38.2K |
|
1125
Atlantic Union Bankshares
AUB
$6.05B
| $937K | ﹤0.01% |
30,841
+2,119
| +7% | +$71.4K |
|
Similar funds
BC
CBU
Natixis Advisors's Q3 2022 Portfolio in Review
As of Q3 2022, Natixis Advisors held 1,542 positions worth $23.6B, up 4% from $22.7B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Natixis Advisors deployed $1.81B of net new capital in Q3 2022, opening 90 new positions and adding to 818 existing holdings. Its largest new stake was Chemed: 52,930 shares worth $23.1M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Vanguard Morningstar Total Stock Market ETF, an estimated $31.5M trimmed.
- Natixis Advisors's largest Q3 2022 buy was Chemed: 52,930 shares worth $23.1M.
- Natixis Advisors added most to Vanguard FTSE Developed Markets ETF in Q3 2022, an estimated $149M increase.
- Natixis Advisors's biggest Q3 2022 reduction was Vanguard Morningstar Total Stock Market ETF, cutting an estimated $31.5M.
- Natixis Advisors fully exited Domino's in Q3 2022, selling an estimated $4.15M.
- Natixis Advisors's ten largest holdings make up 15% of its $23.6B portfolio in Q3 2022.
- Natixis Advisors opened 90 new positions and closed 102 in Q3 2022.
- Natixis Advisors's portfolio value rose 4% quarter-over-quarter to $23.6B.
Based on Natixis Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.